Fifty shades of Troponin - Dr Liam Penny
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Acute Coronary Syndromes Plaque-fissure and intracoronary thrombus Plaque Rupture Old term Stable Unstable Non– Q-wave Angina Angina Q-wave MI MI CPK normal Enymes raised (CPK)
Acute Coronary Syndromes Plaque-fissure and intracoronary thrombus Plaque Rupture Old term Stable Unstable Non– Q-wave Angina Angina Q-wave MI MI New term Stable Angina ACS NSTEMI STEMI Tn - Tn + Tn + Tn ++
Increasing Troponin Predicts increasing Risk Wright, R. S. et al. J Am Coll Cardiol 2011;57:e215-e367
1021 patients 7 yr follow up study
Comparison of Kaplan–Meier Survival for the 2 ACS groups and with the reference population. Wong P S C et al. Postgrad Med J 2012;88:437-442
Comparison of Kaplan–Meier Survival for the two non ACS groups and with the reference population.
Comparison of Kaplan–Meier Survival for the four troponin groups Tn + , non ACS had worst prognosis. Wong P S C et al. Postgrad Med J 2012;88:437-442
Definition of AMI
WHO definition of AMI 1971 • CPK raised > 2 normal – arbitrary level – assay was unreliable with wide inter-individual and intra-individual variations – many other causes of raised CPK
ESC/ AHA 2000 definition of AMI NB Any rise or fall of Tn
New clinical classification of MI Classification Description 1 Spontaneous MI related to ischemia due to a primary coronary event, such as plaque erosion and/or rupture, fissuring, or dissection 2 MI secondary to ischemia due to an imbalance of O2 supply and demand, as from coronary spasm or embolism, anemia, arrhythmias, hypertension, or hypotension 3 Sudden unexpected cardiac death 4a MI associated with PCI 4b MI associated with documented in-stent thrombosis 5 MI associated with CABG surgery Thygesen K et al. Circulation 2007;
ESC/ ACC definition of AMI • Based on more sensitive and more specific Tn assays but ….
Problems with ESC /ACC definition • Wide variation in early Tn assays at low levels – Eg same patient assayed in 2 different laboratories one will determine AMI other will not
Problems with ESC /ACC definition • Tn raised in other conditions apart from ACS – 68% of marathon runners Ann Emerg Med. 2007;49:137-143 – 19.6% of angioplasties but normal CKMB J Am Coll Cardiol 2006;48:1765–70 – Treadmill exercise test ie reversible ischemia not necessarily necrosis – ‘Healthy’ population
RAISED TROPONINS ON A STROKE UNIT: 412 patients with Stroke 70 (29%) patients had positive Tn levels (>0.032 ng/l) NB Must view clinical context to interprete rise in Tn doi:10.1136/heartjnl-2011-300198.4
BCS Working Group Definition of Myocardial Infarction Heart 2004
BCS Working Group proposals 1. ACS with unstable angina Tn – 2. ACS with myocyte necrosis Tn + transient ECG changes 3. ACS with clinical MI evolving ECG changes – Tn I >1.0ng/ml or Tn T >0.5ng/ml • Roughly corresponds with 1971 WHO definition CPK x2 Arbitrary cut-off
2007 Thygesen K et al. Circulation. 2007 Nov 27;116(22):2634-53
Circulation 2012
Electrocardiogram (ECG)
ECG Evolution in ST Elevation Myocardial Infarction 30
ECG can also be non-specific for diagnosing MI
Diagnostic criteria for AMI • Evidence of myocardial necrosis (rise in Tn) in the clinical setting consistent with AMI • At least 1 of the following – Symptoms of Ischaemia – New ST T or LBBB or Q waves – Imaging evidence of new WMA – *Coronary Thrombus at angio or PM Special situations eg Sudden death, PCI/CABG related MI
Wide variation between laboratories in Tn I assay
Troponin level (mcg/L) depends on assay The diagnostic cut-offs used in new definition (99 centile) th are one order of magnitude lower than those proposed by BCS Method 99th centile Original AMI cut off mcg/l mcg/l Abbott AxSym Trop I 0.4 (95th centile) 2.0 Abbott ARCHITECT Trop I 0.012 0.3 ADVIA Centaur cTnI 0.07 (95th centile) 1.5 ADVIA Centaur TnI-Ultra 0.04 0.78 Access Accu TnI 0.04 0.5 Dade Behring Dimension Trop I 0.07 0.6 Dade Behring Stratus Trop I 0.07 0.6 IMMULITE 2500 Trop I 0.2 0.9 Ortho VITROS cTnI 0.08 0.4 Ortho VITROS TropI 0.12 Tosoh AIA Trop I 0.1 0.1 Roche Elecsys Troponin T
Elevation of TN • > 99 upper percentile • COV 5%
Impact of Cardiac Troponins 298 Patients with Chest Pain Admitted to CCU 155 (52%) 127 (43%) 16 (5%) MI by WHO criteria Ischemia Non-Cardiac 100% positive cTnT 44 patients 83 patients Troponin T positive cTnT negative cTnT positive defined as > (15%) 6/44 (14%) 3/83 (4%) 0.2 Death or Mi Death or MI Death or MI micrograms/L in 6 months in 6 months in 6 months Ravkilde J, et al Scand J Clin Lab Invest 1993 Nov;53(7):677-85
Impact of Cardiac Troponins 298 Patients with Chest Pain Admitted to CCU 155 (52%) 127 (43%) 16 (5%) MI by WHO criteria Ischemia Non-Cardiac 100% positive cTnT 44 patients 83 patients positive cTnT negative cTnT Troponin T positive defined as > (15%) 6/44 (14%) 3/83 (4%) 0.2 Death or Mi Death or MI Death or MI micrograms/L in 6 months in 6 months in 6 months Ravkilde J et al, Scand J Clin Lab Invest 1993 Nov;53(7):677-85 37
Acute Coronary Syndromes What about high sensitivity Troponin ?
Raised hs TN • 2% “healthy” adults • Stable Angina • Pulmonary Hypertension • LVH • Heart Failure • Renal Failure
Diagnosis of AMI with hsTn • Requires 2 samples • Show 20% to 50% rise after 3 hrs
High Sensitivity Troponin Detects levels 10X lower than older assays 1. Greater sensitivity 2. Greater precision than older assays 3. Peaks earlier post MI (3hrs) 4. ?positive in some ‘well’ individuals Christ M et al, American J Med (2010) 123, 1134-1142 Mohammed AA et al. Cardiology in Review 2010;18: 12–19 41
Troponin level (mcg/L) depends on assay The diagnostic cut-offs used in new definition (99 centile) th are one order of magnitude lower than those proposed by BCS Method 99th centile Original AMI cut off mcg/l mcg/l Abbott AxSym Trop I 0.4 (95th centile) 2.0 Abbott ARCHITECT Trop I 0.012 0.3 ADVIA Centaur cTnI 0.07 (95th centile) 1.5 ADVIA Centaur TnI-Ultra 0.04 0.78 Access Accu TnI 0.04 0.5 Dade Behring Dimension 0.07 0.6 Trop I Dade Behring Stratus Trop I 0.07 0.6 IMMULITE 2500 Trop I 0.2 0.9 Ortho VITROS cTnI 0.08 0.4 Ortho VITROS TropI 0.12 Tosoh AIA Trop I 0.1 0.1 Roche Elecsys Troponin T
hs Troponin detected in 70% ‘well’ subjects > 65 yrs Baseline Tn predicted Death over 10 yrs. deFilippi, C. R. et al. JAMA 2010;304:2494-2502
hs Troponin elevated in 70% ‘well’ subjects > 65 yrs Baseline Tn predicted Death over 10 yrs. deFilippi, C. R. et al. JAMA 2010;304:2494-2502
Subsequent Change in hs Tn predicts development of Heart Failure and Cardiovascular Death deFilippi, C. R. et al. JAMA 2010;304:2494-2502
Accuracy of Troponin depends on time since pain onset hs Troponin accurate at 2 hrs, standard Tn 12 hrs
Impact of Troponins on MI Incidence Circulation 2003;108:2543-9 47
Impact hsTn vs Tn STEMI diagnosis by 20% old new 48
In Edinburgh introducing hsTn increased myocardial infarction diagnosis by 33% Heart 2011
Acute Myocardial Infarction Other markers to define AMI?
Role of other Biomarkers to define AMI: Copeptin
Copeptin and Tn Levels in Relation to Time Since Onset of Symptoms Copeptin is an early marker Reichlin, T. et al. J Am Coll Cardiol 2009;54:60-68
Acute Myocardial Infacrtion What about adefinition based on Ejection Fraction?
Comparison between Echo and Nuclear EF in same subject
Inter-observer variation Echo mean diff = 18.1% Nuclear mean diff = 3.1%
Other Factors Influencing EF • Load on LV – HT reduces EF (Normal = 0.45) – Optimal treatment (3 months post MI) • Mitral Regurgitation increases EF – If MR, even EF < 0.6 is impaired 56
Conclusions •Level of Tn which can now be reliably measured (99th Percentile and 10% CV) is 1% of original definition recommended by BCS •Consequently in ACS spectrum less Unstable AP and more MI diagnosed TN increased MI diagnosis by 33% hs TN increased MI diagnosis by further 33% •Hs Tn measured in many ‘normals’ and non ACS patients •Interpretation relies not on level but on clinical context
Case Study 1 Modern Treatment further complicates • RP male 55yrs Smoker 2011 Admitted 22.20hrs Pain onset 20.00 hrs ECG ST elevation inferior leads Tn on admission
Case Studies • RP male 55yrs Smoker ECG ?small q waves Echo Normal EF 70% ? Small area inf hypokinesia Conclusion Treated in early hrs of ?threatened inferior MI
Case Study2 Is this a valid claim ?
69 yrs female While standing off stage just before a Ball Room dancing competition became distressed with palpitations and a tightness in her chest. She collapsed. PMH – b/l mastectomy Non smoker, no FH of note Meds - Tamoxifen 20mg /Omeprazole 20mg Examination – unremarkable IX - ECG Troponin T – 0.02
ECG on admission
ECG at 12 hrs
Diagnosis : Acute Coronary Syndrome Transferred that day to UHW because of ongoing pain and ECG changes despite IV Nitrates and LMW Heparin
Echo cardiogram On presentation UHW
Normal right coronary anatomy
Normal left coronary anatomy
Normal left coronary anatomy
Echo cardiogram On presentation UHW
Echo cardiogram At 1 month
???? Diagnosis
TAKO - TSUBO SYNDROME ‘Transient LV apical ballooning’ ‘Reversible cardiomyopathy’
Tako-tsuba Syndrome: Peculiar LV End systolic shape
Tako-tsubo Syndrome Incidence • Probably accounts for >5% ACS Eur Heart J. 2006 Jul;27(13):1523-9.
Left ventricular EF independently predicts prognosis
New Terminology in ACS Plaque Rupture Stable Unstable Non– Q-wave Old term Angina Angina Q-wave MI MI Increasing Tn levels New term Atherothrombosis UA/NSTEMI STEMI Cannon CP. J Thromb Thrombolysis. 1995;2:205-218.
Importance of very small elevations in Tn Kontos et al
68 yrs female collapsed after finding her son in the garage having hanged himself
69 yrs female Christmas Eve shopping her purse was stolen and she became very distressed and collapsed with Chest pain
5 days later
79 yrs female while picking blackcurrants in her garden had a bee sting, became distressed and then about 1 hr later developed chest pain and husband called 999
Histology of Ruptured plaque
Causes of Increased Troponin Mohammed AA et al,Cardiology in Review 2010;18: 12–19 93
You can also read